Generex Provides Update to Pending 1:1 Stock Dividend

NEXT STORY
Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference
PREV STORY
ELIGARD® (Leuprolide Acetate) for Injectable Suspension Continues Growth Momentum With Securing Favorable Formulary Position as the Lowest WAC Priced, and Only Subcutaneously Administered Leuprolide Acetate for the Palliative Treatment of Advanced Prostate Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MacroGenics Highlights Progress at 2016 R&D Day

Advancement of HER2 franchise led by margetuximabExpansion and progression of B7-H3 franchiseIntroduction of PD-1 ...

author_avatar
NASDAQ Market News

Clinical Genomics and Quest Diagnostics extend collaboration to provide InSure® ONE™, a fecal immunochemical test for colorectal cancer screening programs

Relationship ensures broad access to innovative FIT test in the U.S. BRIDGEWATER, N.J., and ...

author_avatar
NASDAQ Market News

Calithera Biosciences to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology Roundtable

SOUTH SAN FRANCISCO, Calif., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News